Fact CheckerSign in

NCT05993897Completed

Effect of Sodium Glucose Co-transporter 2 Inhibitors on Left Atrial Remodeling

Effect of Sodium Glucose Co-transporter 2 Inhibitors on Left Atrium Remodeling in Non-valvular Paroxysmal Atrial Fibrillation Patients

Source: ClinicalTrials.gov · Last updated 13 Jul 2026

Brief summary (registry, in English)

Investigators are going to assess direct effect of SGLT2 inhibitors on left atrial remodeling in participants with nonvalvular paroxysmal atrial fibrillation regardless of diabetes status.

Status (registry)
Completed
Study type
Interventional
Enrollment
60 (actual)
First submitted
25 Jul 2023
Start date
20 Aug 2024
Primary completion date
30 Jun 2025
Lead sponsor
Aswan University
NCT number
NCT05993897

What you commit to

  • Study type: Interventional
  • Participants enrolled: 60
  • From 20 Aug 2024 to the primary completion date, 30 Jun 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patient with ischemic heart disease (previous MI, UA, PCI or CABG).
  • Patient with previous ischemic stroke.

Other illness

  • Patients with valvular heart diseases (Moderate to severe MS, severe AS, Prosthetic heart valves).

Lab values

  • Patients with glomerular Filtration Rate (GFR) \<45 ml/min/1.73m2 (Cockcroft-Gault equation).

Age

  • Patients \< 18 yrs old.

Other

  • Patients with left atrium \> 5cm.

Who the study is looking for

  • with non-valvular paroxysmal atrial fibrillation (AF that terminates spontaneously or with intervention within seven days of onset).
  • Patient age 18-60 years.
  • Patients with Glomerular Filtration Rate (GFR) \>45 ml/min/1.73m2 (Cockcroft-Gault equation).
  • Patient with normal left atrium or dilated (diameter \<5 cm)

Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Aswan university
Coordinator of this site? Confirm its status
AswānEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.